Comparative efficacy of individual renin–angiotensin system inhibitors on major renal outcomes in diabetic kidney disease: a network meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy of individual renin–angiotensin system inhibitors on major renal outcomes in diabetic kidney disease: a network meta-analysis

Published:2018-03-22 Issue:11 Volume:33 Page:1968-1976
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Cai Juyu¹²,Huang Xianxi³⁴,Zheng Zhongsheng²,Lin Qing⁵,Peng Mian⁶,Shen Daoqian⁷

Affiliation:

1. Cardiovascular Research Center, Shantou University Medical College, Shantou, China

2. Department of Internal Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China

3. Laboratory of Molecular Cardiology, Shantou University Medical College, Shantou, China

4. Intensive Care Unit, The First Affiliated Hospital of Shantou University Medical College, Shantou, China

5. Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

6. Intensive Care Unit, The Fifth People's Hospital of Shenzhen City, Shenzhen, China

7. Department of respiratory medicine, Zhangjiajie City Hospital, Zhangjiajie, Hunan, China

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/33/11/1968/26182594/gfy001.pdf

Reference49 articles.

1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;Wild;Diabetes Care,2004

2. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013;Vos;Lancet,2015

3. Nephropathy in patients with type 2 diabetes mellitus;Ritz;N Engl J Med,1999

4. KDOQI clinical practice guideline for diabetes and CKD: 2012 update;National Kidney Foundation;Am J Kidney Dis,2012

5. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease;Strippoli;Cochrane Database Syst Rev,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A molecular mechanism for angiotensin II receptor blocker‐mediated slit membrane protection: Angiotensin II increases nephrin endocytosis via AT1‐receptor‐dependent ERK 1/2 activation;The FASEB Journal;2024-08-30

2. Potentials of Natural Antioxidants in Reducing Inflammation and Oxidative Stress in Chronic Kidney Disease;Antioxidants;2024-06-20

3. Niclosamide from an anthelmintic drug to a promising adjuvant therapy for diabetic kidney disease: randomized clinical trial;Diabetology & Metabolic Syndrome;2023-02-16

4. Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review;Frontiers in Pharmacology;2023-02-13

5. The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD;Diabetology & Metabolic Syndrome;2022-06-11